- 专利标题： Benzofuran compounds for the treatment of hepatitis C
-
申请号： US15551002申请日： 2016-02-17
-
公开(公告)号： US10125111B2公开(公告)日： 2018-11-13
- 发明人: Tao Wang , Zhiwei Yin , Zhongxing Zhang , John F. Kadow
- 申请人： BRISTOL-MYERS SQUIBB COMPANY
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理商 James Epperson
- 国际申请： PCT/US2016/018151 WO 20160217
- 国际公布： WO2016/133948 WO 20160825
- 主分类号： C07D307/82
- IPC分类号： C07D307/82 ; C07D307/84 ; C07D405/04 ; C07D405/12
摘要：
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus, (HCV) and may be useful in treating those infected with HCV.
公开/授权文献
- US20180030016A1 BENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C 公开/授权日：2018-02-01
信息查询
